NASA has confirmed that the agency, in coordination with SpaceX, is targeting no earlier than 5 p.m. Eastern Time (2200 GMT) on Wednesday, January 14, for the undocking of the SpaceX Crew-11 mission from the International Space Station (ISS). The planned departure remains dependent on favorable weather conditions, which are a key factor in ensuring a safe return to Earth for the astronauts aboard the mission.
The announcement comes amid heightened attention after NASA disclosed earlier this week that it was considering an early return of the ISS crew due to what the agency described as a “medical concern” involving one of the astronauts. While NASA has not released specific details regarding the nature of the medical issue, officials emphasized that the health and safety of the crew remain the top priority and that contingency plans are a routine part of human spaceflight operations.
The SpaceX Crew-11 mission is part of NASA’s Commercial Crew Program, which relies on SpaceX’s Crew Dragon spacecraft to transport astronauts to and from the ISS. The mission has been docked at the orbiting laboratory while the crew carried out a range of scientific experiments, technology demonstrations, and station maintenance tasks critical to ongoing space research.
NASA stated that mission managers are continuing to closely monitor the astronaut’s condition, overall crew readiness, spacecraft performance, and weather patterns at the designated splashdown zones. Any changes to the undocking timeline will be communicated as more information becomes available.
The potential early undocking highlights the flexibility built into modern space missions, allowing agencies like NASA and partners such as SpaceX to respond quickly to unforeseen situations. As the target date approaches, space enthusiasts and industry observers will be watching closely for updates on the Crew-11 return, the astronaut’s health status, and how the mission concludes.
For now, NASA maintains that the January 14 undocking window remains the earliest opportunity, pending final assessments, underscoring the careful balance between mission objectives and astronaut well-being in human spaceflight.


Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Neuralink Expands Brain Implant Trials with 12 Global Patients
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 



